Beth Alwyn

Beth Alwyn is a seasoned quality management professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Director of Global Product Quality - Quality Risk Management at BioNTech SE since February 2024, Beth previously held the role of Director, Head of Quality Risk Management and Quality Systems at Resilience, where responsibilities included developing and maintaining quality risk management programs and leading the implementation of a Quality Management System. Prior to this, Beth contributed to quality systems at Homology Medicines, Inc., Sanofi, and Lonza, driving compliance and continuous improvement initiatives. Educational credentials include a Bachelor’s Degree in Leadership from Northeastern University and an Associate in Science in Biotechnology from Great Bay College.